.png){kind=icon}
-
End-to End Support to Advance Gene Therapies for Rare Retinal Diseases
Case StudiesJun. 23, 2020
As a promising therapeutic candidate targeting rare inherited retinal diseases was spun out of an academic medical center, Covance served an integral role performing analytical testing of their product and ensure the project followed an expedited timeline.
As a promising therapeutic candidate targeting rare inherited retinal diseases was spun out of an academic medical center, Covance served an integral role performing analytical testing of their product and ensure the project followed an expedited timeline.
